NRC National Research Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: NRC

Price (delayed)

$21.25

Market cap

$470.04M

P/E Ratio

88.54

Dividend/share

$0.6

EPS

$0.24

Enterprise value

$556.74M

?
Relative Growth: Rel. Growth: 8
Relative Strength: Rel. Strength: 82
Relative Valuation: Rel. Valuation: 22
Relative Profitability: Rel. Profitability: 67
Highlights
The gross margin has grown by 2.3% year-on-year
NRC's gross profit is up by 2.2% year-on-year
The quick ratio has declined by 27% year-on-year but it has grown by 2.9% since the previous quarter
The stock's price to earnings (P/E) is 184% more than its 5-year quarterly average of 31.2 and 86% more than its last 4 quarters average of 47.5
The EPS has dropped by 69% year-on-year and by 37% since the previous quarter
Sector: Healthcare
Industry: Health Information Services
Website: http://nrchealth.com

Key stats

What are the main financial stats of NRC

NRC stock price

How has the National Research stock price performed over time
Intraday
6.2%
1 week
-3.45%
1 month
8.97%
1 year
44.26%
YTD
13.21%
QTD
-1.48%

Financial performance

How have National Research's revenue and profit performed over time
Revenue
$140M
Gross profit
$86.45M
Operating income
$14.74M
Net income
$5.86M
Gross margin
61.7%
Net margin
4.2%
National Research's net margin has shrunk by 67% YoY and by 35% QoQ
NRC's net income has shrunk by 67% YoY and by 35% QoQ
National Research's operating margin has decreased by 47% YoY and by 26% QoQ
NRC's operating income is down by 47% YoY and by 25% QoQ

Price vs fundamentals

How does NRC's price correlate with its fundamentals

Growth

What is National Research's growth rate over time

Valuation

What is National Research stock price valuation
NRC P/E details
P/E
88.54
P/B
73.13
P/S
3.34
EV/EBIT
37.65
EV/EBITDA
23.77
EV/Sales
3.98
The stock's price to earnings (P/E) is 184% more than its 5-year quarterly average of 31.2 and 86% more than its last 4 quarters average of 47.5
The EPS has dropped by 69% year-on-year and by 37% since the previous quarter
NRC's price to book (P/B) is 90% more than its last 4 quarters average of 38.5
National Research's equity has shrunk by 69% YoY and by 51% QoQ
The P/S is 35% lower than the 5-year quarterly average of 5.1 but 19% higher than the last 4 quarters average of 2.8

Efficiency

How efficient is National Research business performance
The return on assets has dropped by 68% year-on-year and by 35% since the previous quarter
NRC's return on invested capital has dropped by 56% year-on-year and by 26% since the previous quarter
The return on sales has declined by 46% year-on-year and by 25% since the previous quarter
NRC's return on equity is down by 21% year-on-year and by 15% since the previous quarter

Dividends

What is NRC's dividend history
Dividend details
DPS
$0.6
Dividend yield
2.82%
Payout ratio
250%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did National Research financials performed over time
NRC's total assets is 5% greater than its total liabilities
The quick ratio has declined by 27% year-on-year but it has grown by 2.9% since the previous quarter
NRC's current ratio is up by 25% QoQ but it is down by 7% YoY
NRC's debt to equity has soared by 138% QoQ
National Research's equity has shrunk by 69% YoY and by 51% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.